Presentation TCT 2016 Good and Not So Good Cases to Consider for Alcohol Septal Ablation Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD! Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel October 30, 2016
Presentation TCT 2016 Obtaining Informed Consent: The Essentials and How to Succeed in Difficult Scenarios Presenter: David A. Cox, Thomas D. Stuckey, Timothy D. Henry October 30, 2016
Presentation TCT 2016 When Is Pacing Needed in HCM Outside Invasive Management Settings Presenter: Bernard J. Gersh, Harry Rakowski October 30, 2016
Presentation TCT 2016 How to Be a Key Investigator? Its Not Just Quantity- Quality Is Top Priority Presenter: David A. Cox, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Medical Management of Non-Obstructive HCM: When and Which Medications? Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Quality and Compliance in Research: The Crucial First Step Presenter: David A. Cox, Thomas D. Stuckey, Kate Dalton October 30, 2016
Presentation TCT 2016 Building a Successful Clinical Research Enterprise at Your Hospital: Integrating Clinical Work Flow and Research Presenter: David A. Cox, Thomas D. Stuckey, Tamim Nazif October 30, 2016
Presentation TCT 2016 Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts October 30, 2016
Presentation TCT 2016 Cardiac Catheterization Is Essential for Hemodynamic Assessment Presenter: Howard C. Herrmann, Sherif F. Nagueh October 30, 2016
Presentation TCT 2016 Cardiac MR for Diagnosis and Guiding Management of HCM Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai October 30, 2016
Presentation TCT 2016 TAVR in Patients With Poor Femoral Access Presenter: Neal S. Kleiman, Patrick T. O'Gara, Richard Smalling October 30, 2016
Presentation TCT 2016 Echocardiography Essentials for Comprehensive Evaluation of HCM Presenter: Howard C. Herrmann, Sherif F. Nagueh October 30, 2016
Presentation TCT 2016 Severe AS and Extreme Co-morbidities (Futile Patient?) Presenter: Neal S. Kleiman, Patrick T. O'Gara, Suzanne V. Arnold October 30, 2016
Presentation TCT 2016 Management of Failing Aortic Bioprosthesis Presenter: Neal S. Kleiman, Patrick T. O'Gara, Danny Dvir October 30, 2016
Presentation TCT 2016 TAVR in Patients With Atrial Fibrillation Presenter: Neal S. Kleiman, Patrick T. O'Gara, Fabian Nietlispach October 30, 2016
Presentation TCT 2016 My Rosy Prophecy: What Will the Specialty of Mitral Valve Therapeutics Look Like in 10 Years? Presenter: James S. Gammie, James B. Hermiller Jr., Alec S. Vahanian October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard! Presenter: James S. Gammie, James B. Hermiller Jr., Steven F. Bolling October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective! Presenter: James S. Gammie, James B. Hermiller Jr., Ted Feldman October 30, 2016